Treatment GuideJust DiagnosedSex & DatingAfrican AmericanStigmaAsk the HIV DocPrEP En EspañolNewsVoicesPrint IssueVideoOut 100
CONTACTCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2024 Pride Publishing Inc.
All Rights reserved
All Rights reserved
By continuing to use our site, you agree to our Private Policy and Terms of Use.
In 1981, I published the first of eight review articles on the immunostimulating and antimicrobial properties of lithium and antidepressant medications. In one review I proposed that to stimulate immune function an agent must have mood-elevating properties. Thus, antidepressants and lithium may be unique in possessing this property. Let me explain how this works. Prostaglandins are tiny and short-lived -- but powerful -- molecules that self-regulate the physiology of every cell, including those of the immune system. When prostaglandins are synthesized excessively, cellular function becomes dysfunction. Prostaglandins also control the physiology, immunity, replication, and toxicity of microorganisms. The virulence of a virus is determined by the ability of its human host cell to resist it and the virus's ability to induce prostaglandin E2 synthesis. HIV is exceptionally powerful in inducing prostaglandin E2 synthesis. And when induced excessively, these molecules depress immune system function. In fact, prostaglandin E2 is thought to be the most powerful immunosuppressant produced in the body and a key contributor to HIV's ability to suppress and kill CD4 immune system cells. The failure of such standard prostaglandin inhibitors as aspirin and ibuprofen in preventing HIV from stimulating prostaglandin E2 production in lab tests led many researchers to reach the conclusion that this approach was ineffective as a potential HIV treatment. However, research conducted in the mid 1970s showed that other compounds -- specifically antidepressants ' do indeed prevent the synthesis of prostaglandin E2 or block its actions. These studies showed that lithium blocked a similar compound, called prostaglandin E1, and that both lithium and other antidepressant medications inhibited enzymes involved in the production of prostaglandins that aspirin and ibuprofen do not affect. Antidepressants also have been shown to have immunostimulating, antibacterial, antiviral, antiparasite, and fungicidal properties as well as the ability to heighten the effects of antibiotics. Specifically, lithium may be useful in treating methicillin-resistant staphylococcus aureus infections (MRSA) and hospital-acquired infections. Monoamine oxidase inhibitors (MAOIs) also may be useful in reversing various viral and bacterial infections. At least 70 published studies additionally show that antidepressants have clinically relevant anticancer actions, which is not surprising given their ability to stimulate immune function. But despite this laundry list of potential health benefits, little research has been done with regard to the use of antidepressant medications as disease and infection treatments. Perhaps that is because antidepressant medications are cheap, costing just $1 to $3 per day. It would seem, unfortunately, that medications promising to save a fortune rather than create one have little appeal to researchers. So where do we go from here? Randomized clinical trials would be highly unethical, given the pressing worldwide need for immunostimulants. Such trials also would likely involve only one or two antidepressants, and could not be generalized to the others. But similarly unethical, in my opinion, is that fact that throughout the AIDS epidemic not one prominent person or institution has come forward to support the clinical application of antidepressant medications to HIV-positive adults. We should have had answers to the following questions many years ago. Can antidepressants: > Stimulate the immune system to eradicate HIV? > Prevent HIV from replicating? > Prevent or reverse opportunistic infections? > Prevent or reverse HIV-related cancers? But instead of providing us with these answers, scientists and the media -- including both the lay media and respected medical journals -- remain silent, leaving it to HIV-positive individuals themselves to learn more about this potential resource. In that light, I urge you to do your own research on the topic. A good place to start is federal PubMed website, at www.ncbi.nlm.nih.gov/pubmed. Simply search on a few key words (among them immunostimulants, antidepressants, prostaglandin E2, and even my name, Julian Lieb) to find out more. And be sure to print out abstracts or copies of the articles and studies you find so you can show them to your doctor and discuss if antidepressant medications might be right for you. Lieb was a professor of psychiatry at Yale University and the director of the Dana Psychiatric Clinic in New Haven, Conn., before becoming an immunopharmacology researcher. He has authored or coauthored 45 articles and nine books.
From our Sponsors
Most Popular
Before AIDS, gay artist Rex drew hot men on the prowl — then he disappeared
April 11 2024 3:15 PM
The science behind U=U has been liberating people with HIV for years
June 04 2024 3:31 PM
On Anal Sex Day, crack up with The Bottom's Digest
April 18 2024 10:22 AM
As Pride party season begins, the CDC urges mpox vaccinations
May 16 2024 6:52 PM
Todrick Hall has long supported the communities he comes from
April 17 2024 12:02 PM
The freedom of disclosure: David Anzuelo's journey through HIV, art, and advocacy
August 02 2024 12:21 PM
Exclusive: We kiki with Q from 'RuPaul's Drag Race'
June 24 2024 11:37 AM
Plus: Featured Video
Latest Stories
How fitness coach Tyriek Taylor reclaims his power from HIV with self-commitment
September 19 2024 12:00 PM
Out100 Honoree Tony Valenzuela thanks queer and trans communities for support in his HIV journey
September 18 2024 12:00 PM
Kentucky bans conversion therapy for youth as Gov. Andy Beshear signs 'monumental' order
September 18 2024 11:13 AM
Why activist Raif Derrazi thinks his HIV diagnosis is a gift
September 17 2024 12:00 PM
Creator and host Karl Schmid fights HIV stigma with knowledge
September 12 2024 12:03 PM
Study finds use of puberty blockers safe and reversible, countering anti-trans accusations
September 11 2024 1:11 PM
Latinx health tips / Consejos de salud para latinos (in English & en espanol)
September 10 2024 4:29 PM
The Trevor Project receives $5M grant to support LGBTQ+ youth mental health in rural Midwest (exclusive)
September 03 2024 9:30 AM
Introducing 'Health PLUS Wellness': The Latinx Issue!
August 30 2024 3:06 PM
La ciencia detrás de U=U ha estado liberando a las personas con VIH durante años
August 23 2024 2:48 PM
Tratamiento y prevención del VIH por inyección: Todo lo que necesita saber
August 23 2024 2:41 PM
Sr. Gay World quiere asegurarse de que estés bien
August 23 2024 2:30 PM
Eureka is taking a break from competing on 'Drag Race' following 'CVTW' elimination
August 20 2024 12:21 PM
With a new case in Sweden, what is the new mpox outbreak and should you be concerned?
August 15 2024 4:48 PM
From ‘The Real World’ to real life: How Danny Roberts thrives with HIV
July 31 2024 5:23 PM
The July/Aug 'Treatment Guide' issue of Plus is here!
June 26 2024 3:49 PM
Activist and philanthropist Bruce Bastian dies at 76
June 26 2024 1:28 PM